This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:
New research simultaneously published in the Journal of the Society for Cardiovascular Angiography & Interventions and presented at TCT 2026 found that the annual number of transcatheter aortic valve replacement (TAVR) procedures among patients younger than 70 increased nearly ninefold within one health system, rising from 15 in 2014 to 134 in 2024. Surgical aortic valve replacement (SAVR) remained the predominant approach across the age groups studied.
The study, "Temporal Trends in Utilization and Early Outcomes of Transcatheter Versus Surgical Aortic Valve Replacement in Patients Younger Than 70 Years," retrospectively analyzed 5,755 procedures performed across the Baylor Scott & White Health system over 11 years, including 1,008 TAVR procedures and 4,747 SAVR procedures. The increase in TAVR was driven primarily by patients aged 60 to 69, among whom annual volume rose from 14 procedures in 2014 to 121 in 2024. Within the health system, TAVR use among patients younger than 60 remained comparatively limited.
TAVR is a minimally invasive procedure that delivers a replacement valve through a catheter, typically without opening the chest, and generally allows for a shorter recovery than SAVR, which involves open-heart surgery. For younger patients, the treatment decision can be particularly complex because the initial procedure may affect future treatment options. "Among those with substantial anticipated longevity, bioprosthetic valve durability, structural valve deterioration and the potential need for subsequent interventions are central considerations," the authors wrote.
Source link







